Disease | proteinuria |
Phenotype | C0011860|type 2 diabetes mellitus |
Sentences | 3 |
PubMedID- 23209764 | The selective vitamin d receptor (vdr) activator, paricalcitol, effectively reduces proteinuria in patients with type 2 diabetes mellitus (t2dm) who have been treated with raas inhibitors [6]. |
PubMedID- 22218118 | Angiotensin receptor blocker and n-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus. |
PubMedID- 25893098 | Monitoring for proteinuria in patients with type 2 diabetes mellitus. |
Page: 1